Literature DB >> 1371775

Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.

R Alam1, M A Lett-Brown, P A Forsythe, D J Anderson-Walters, C Kenamore, C Kormos, J A Grant.   

Abstract

Monocyte chemotactic and activating factor (MCAF) is a recently cloned cytokine that causes chemotaxis of basophils. In our pursuit of cytokines affecting basophil function, we studied the effect of MCAF on histamine secretion from basophils. Leukocytes from 20 donors, 10 allergic and 10 normal subjects, were studied. MCAF caused dose-dependent release of histamine at concentrations of 10(-8) and 10(-7) M, and the mean release was 31.25 +/- 2.9% at the highest concentration. In the same experiments the mean histamine release by anti-IgE and histamine releasing factor (HRF) was 27.05 +/- 4% and 32.70 +/- 2.7%, respectively. All 20 subjects responded to MCAF with significant histamine release. Allergic subjects released significantly more histamine than normals in response to anti-IgE (P less than 0.01) but not to MCAF (P = 0.2) and HRF (P = 0.1). The histamine release was significantly correlated between MCAF and HRF (P less than 0.01), but not between MCAF and anti-IgE (P greater than 0.05). The histamine release by MCAF was complete within the first 3 min. MCAF-induced degranulation was a calcium-dependent process. Leukocytes depleted of monocytes responded equally well to MCAF. Using an anti-MCAF affinity column we determined that greater than 50% of HRF activity of crude PBMC supernatant could be attributed to MCAF. Thus, we established that MCAF is a potent secretagogue for basophils.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371775      PMCID: PMC442914          DOI: 10.1172/JCI115648

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions.

Authors:  J A Warner; M M Pienkowski; M Plaut; P S Norman; L M Lichtenstein
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

2.  Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.

Authors:  M A Lett-Brown; D A Boetcher; E J Leonard
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

3.  Cellular origin of histamine-releasing factor produced by peripheral blood mononuclear cells.

Authors:  R Alam; P A Forsythe; M A Lett-Brown; J A Grant
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

4.  Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE.

Authors:  T Yoshimura; N Yuhki; S K Moore; E Appella; M I Lerman; E J Leonard
Journal:  FEBS Lett       Date:  1989-02-27       Impact factor: 4.124

5.  Comparative effect of recombinant IL-1, -2, -3, -4, and -6, IFN-gamma, granulocyte-macrophage-colony-stimulating factor, tumor necrosis factor-alpha, and histamine-releasing factors on the secretion of histamine from basophils.

Authors:  R Alam; J B Welter; P A Forsythe; M A Lett-Brown; J A Grant
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

6.  Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity.

Authors:  H A Sampson; K R Broadbent; J Bernhisel-Broadbent
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

7.  Sensitivity of basophils to histamine releasing factor(s) of various origin: dependency on allergic phenotype of the donor and surface-bound IgE.

Authors:  R Alam; P A Forsythe; J A Rankin; M C Boyars; M A Lett-Brown; J A Grant
Journal:  J Allergy Clin Immunol       Date:  1990-07       Impact factor: 10.793

8.  The magnitude of the spontaneous production of histamine-releasing factor (HRF) by lymphocytes in vitro correlates with the state of bronchial hyperreactivity in patients with asthma.

Authors:  R Alam; P Kuna; J Rozniecki; B Kuzminska
Journal:  J Allergy Clin Immunol       Date:  1987-01       Impact factor: 10.793

9.  Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release.

Authors:  M Haak-Frendscho; N Arai; K Arai; M L Baeza; A Finn; A P Kaplan
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

10.  Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line.

Authors:  C O Zachariae; A O Anderson; H L Thompson; E Appella; A Mantovani; J J Oppenheim; K Matsushima
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2.

Authors:  W A Kuziel; S J Morgan; T C Dawson; S Griffin; O Smithies; K Ley; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 3.  IgE-dependent histamine-releasing factors.

Authors:  H A Sampson; S M MacDonald
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus.

Authors:  B Olszewska-Pazdrak; A Casola; T Saito; R Alam; S E Crowe; F Mei; P L Ogra; R P Garofalo
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 5.  Chemokines and chemokine receptors: their role in allergic airway disease.

Authors:  M E Rothenberg; N Zimmermann; A Mishra; E Brandt; L A Birkenberger; S P Hogan; P S Foster
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

6.  Differential response of human basophils and mast cells to recombinant chemokines.

Authors:  W Füreder; H Agis; H Semper; F Keil; U Maier; M R Müller; K Czerwenka; H Höfler; K Lechner; P Valent
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

7.  Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor.

Authors:  Y Nakano; T Kasahara; N Mukaida; Y C Ko; M Nakano; K Matsushima
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Airway responses to aerosolized brevetoxins in an animal model of asthma.

Authors:  William M Abraham; Andrea J Bourdelais; Juan R Sabater; Ashfaq Ahmed; Troy A Lee; Irakli Serebriakov; Daniel G Baden
Journal:  Am J Respir Crit Care Med       Date:  2004-09-24       Impact factor: 21.405

9.  Effects of basophil-priming and stimulating cytokines on histamine release from isolated human skin mast cells.

Authors:  M Nitschke; K Sohn; D Dieckmann; B F Gibbs; H H Wolff; U Amon
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

10.  Progress and challenges in the understanding of chronic urticaria.

Authors:  Marta Ferrer; Allen P Kaplan
Journal:  Allergy Asthma Clin Immunol       Date:  2007-03-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.